Loading...
01/11 04:03
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates a challenging outlook. Revenue guidance is weak, with no revenue expected in Q1 2025 and minimal guidance for Q2. Operating expenses are rising, and the net loss has increased. The absence of a share buyback or dividend program further dampens sentiment. The Q&A reveals partnership risks and regulatory challenges. Despite some positive developments in technology and partnerships, the financial performance and guidance overshadow these, leading to a negative sentiment.
GAAP net loss $5,200,000 (17¢ per share), compared to a net loss of $4,800,000 (19¢ per share) in Q1 2024.
GAAP operating expenses $5,500,000, an increase of $448,000 from $5,000,000 in Q1 2024, due to a $397,000 increase in R&D expenses and a $277,000 increase in G&A expenses, partly offset by a $226,000 decline in sales and marketing expenses.
Non-GAAP net loss $4,400,000, compared to a loss of $4,000,000 in Q1 2024, due to a $468,000 increase in non-GAAP operating expenses.
Cash, cash equivalents, and short-term investments $24,100,000 as of 03/31/2025, down from $26,800,000 on 12/31/2024.
Cash used in operating activities $4,800,000 in Q1 2025, compared to $4,100,000 in Q1 2024 and $3,000,000 in Q4 2024.
Non-GAAP operating expenses for 2025 Expected to be in the range of $17,250,000 to $17,750,000.
Outsourced fabrication expenses Expected to approach historical levels of $1,200,000 per year as the year progresses.
GaN Devices: Completed the world’s first GaN devices produced using MST technology, indicating improved electrical performance.
MST Technology: MST technology is being leveraged to improve GaN growth on silicon substrates, with a market forecast exceeding $2 billion by the end of the decade.
DRAM Patents: New patents granted focused on DRAM sense amplifiers relevant for high bandwidth and standard DDR memories.
LNA Improvements: Significant interest from mobile phone manufacturers for improvements in low noise amplifiers (LNAs) to meet 5G demands.
EPI Market Growth: The EPI equipment market is expected to reach approximately $2.6 billion by 2027, with a CAGR of 10% to 15%.
Compound Semiconductors: Expansion into gallium nitride (GaN) market, with applications in consumer power supplies and automotive electrification.
Partnership with Capital Equipment Provider: A partnership with a major capital equipment provider aims to accelerate production and sales in gate all around architectures.
Customer Engagement: Active discussions with multiple customers across various technology areas, including RF SOI and advanced nodes.
Recruitment: Actively recruiting for engineering and sales teams to support transition to high volume production.
Focus on AI Infrastructure: Work on gate all around and memory technologies is directly tied to the semiconductor industry's push for AI infrastructure.
Sales and Marketing Strategy: Collaboration with the capital equipment partner will enhance sales and marketing efforts to close designs within large customer organizations.
Partnership Risks: The partnership with a major capital equipment provider may face challenges related to the partner's commitment and resource allocation, as they have budget constraints and may prioritize their own interests.
Customer Demand: There is a risk that customer demands for more detailed and specific silicon results could lead to increased costs and complexity in testing, potentially delaying production timelines.
Regulatory Issues: The company must navigate regulatory uncertainties as highlighted in their filings with the SEC, which could impact their business operations and financial performance.
Supply Chain Challenges: The reliance on multiple vendors for outsourced fabrication services may introduce supply chain risks, particularly if these vendors face operational issues or capacity constraints.
Economic Factors: Economic volatility could affect customer spending and investment in semiconductor technologies, impacting Atomera's revenue and growth prospects.
Operational Expenses: Rising operational expenses, particularly in R&D and legal costs, could strain financial resources and affect profitability.
Market Competition: Intense competition in the semiconductor industry may pose risks to market share and pricing power, particularly as new technologies emerge.
Technology Adoption: The adoption of Atomera's MST technology in new applications, such as GaN, may face delays or challenges in proving its effectiveness to potential customers.
Partnership with Major Capital Equipment Provider: Atomera has announced a partnership with a major capital equipment provider to leverage their expertise and resources to accelerate the development and production of advanced material solutions, particularly in gate all around architectures.
Focus on Advanced Nodes and EPI Market: The partnership aims to enhance Atomera's capabilities in advanced node applications, with the EPI equipment market projected to reach approximately $2.6 billion by 2027, growing at a CAGR of 10% to 15%.
Expansion into GaN Applications: Atomera is actively working on gallium nitride (GaN) applications, with a market forecast to exceed $2 billion by the end of the decade, growing at a 40% CAGR.
Progress with STMicro: Atomera is making significant progress with STMicro in optimizing manufacturability, yield, and throughput for high-volume manufacturing, with ongoing discussions for new licenses in other product areas.
Q2 Revenue Guidance: For Q2, revenue is expected to be in the range of $0 to $50,000, depending on the timing of wafer shipments to the fabless licensee.
2025 Non-GAAP Operating Expense Guidance: The expected non-GAAP operating expense for 2025 is revised to be in the range of $17.25 million to $17.75 million.
Cash Position: As of March 31, 2025, Atomera's cash, cash equivalents, and short-term investments totaled $24.1 million.
Future Revenue Milestones: The next major revenue milestone under the agreement with STMicro will occur when they enter formal process qualification.
Share Buyback Program: None
Dividend Program: None
The earnings call revealed a mixed outlook. While there are promising advancements in technology and partnerships, the financial performance showed increased losses, and there were delays in key projects. The Q&A session highlighted uncertainties, especially with STMicro's decision and lack of clear timelines for transformative projects. The financial health appears strained with rising expenses, and cash reserves are decreasing. These factors, combined with the lack of immediate revenue catalysts and unclear guidance, suggest a negative sentiment towards the stock in the short term.
The earnings call reflects mixed sentiments. The partnership with STMicro and interest from other companies are positive, but the financial performance shows increasing losses and uncertain revenue guidance. The Q&A reveals confidence in milestone payments and other companies' interest, but there's uncertainty in the timeline and execution risks. The unclear management responses and regulatory uncertainties add to the neutral sentiment. Without a clear market cap, the prediction remains neutral, indicating a potential stock price movement between -2% to 2%.
The earnings call revealed a missed EPS target and lack of future revenue guidance, which are negative indicators. While a new partnership was announced, its impact is limited due to non-disclosure of the partner's identity. The Q&A highlighted competitive and partnership risks, with unclear management responses adding to uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
The earnings call reveals several negative factors: a net loss increase, higher operating expenses, no revenue in Q1 2025, and cash flow challenges. Despite optimistic guidance and R&D progress, the reliance on a few key customers and competitive pressures pose risks. The Q&A highlights management's lack of transparency, further unsettling investors. The ATM facility and cash position offer some stability, but overall, the financial health and market uncertainties suggest a negative outlook for the stock price.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
